The latest announcement is out from Globus Medical ( (GMED) ).
On April 3, 2025, Globus Medical completed its acquisition of Nevro Corp., a global medical device company specializing in chronic pain solutions. This strategic acquisition, which positions Globus to expand its presence in the musculoskeletal market, unlocks a $2 billion market opportunity and aims to enhance the company’s product portfolio in the neuromodulation space.
More about Globus Medical
Globus Medical, Inc. is a leading global musculoskeletal company dedicated to solving unmet clinical needs and changing lives through innovations in spine, orthopedic trauma, joint reconstruction, biomaterials, and enabling technologies.
YTD Price Performance: -7.74%
Average Trading Volume: 1,338,615
Technical Sentiment Signal: Sell
Current Market Cap: $11.74B
For detailed information about GMED stock, go to TipRanks’ Stock Analysis page.